COVID-19 studies are our top priority.

For new and updated trial submissions, we are processing trials as quickly as possible and appreciate your patience. We recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from

For full trial details, please see the original record at

Registration number
Ethics application status
Date submitted
Date registered
Date last updated

Titles & IDs
Public title
Cryotherapy Intervention for Docetaxel-induced Nail Toxicities
Scientific title
Nurse-initiated Cryotherapy Intervention for Docetaxel-induced Nail Toxicities: Case-control Study
Secondary ID [1] 0 0
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Effects of Chemotherapy 0 0
Condition category
Condition code

Study type
Description of intervention(s) / exposure
Treatment: Devices - Frozen gel glove (Elasto-Gel Mitten)

Experimental: Frozen gel glove (Elasto-Gel Mitten) - Cryotherapy hand

No Intervention: No frozen glove therapy - Usual care

Treatment: Devices: Frozen gel glove (Elasto-Gel Mitten)
Gel glove is frozen for > 3 hours at -5 to -30°C prior to use. Each patient wears a triple glove set (surgical glove overlaid with cotton glove, overlaid with gel glove) on their intervention hand. Gloves are worn for duration of infusion (15 mins pre, 60 minutes intratreatment and 15 mins post) to ensure the patients' peripheries are vasoconstricted on commencement of the infusion and for enough time afterwards to ensure circulating drug does not reach the target area. Because of the duration of the infusion, more than one gel glove will be used successively (for 45 minutes each) to maintain a consistently low temperature on the hand and nails.

Intervention code [1] 0 0
Treatment: Devices
Comparator / control treatment
Control group

Primary outcome [1] 0 0
Differences in the incidence and severity of nail and skin toxicities between protected and unprotected hands
Timepoint [1] 0 0
12 months
Secondary outcome [1] 0 0
Safety and tolerability of frozen glove treatment
Timepoint [1] 0 0
12 months
Secondary outcome [2] 0 0
Adequacy of infection control measure added to glove protocol
Timepoint [2] 0 0
12 months

Key inclusion criteria
- patients receiving docetaxel as mono- or combination therapy

- patients with no nail disorders at the start of treatment

- life expectancy of at least 3 months
Minimum age
18 Years
Maximum age
No limit
Both males and females
Can healthy volunteers participate?
Key exclusion criteria
- patients previously treated with taxane chemotherapy

- Raynaud's phenomenon

- distal metastases

- ungual pathology

- arteriopathy

- cold intolerance

- peripheral neuropathy of grade 2 or higher

- patients currently enrolled in clinical trials

Study design
Purpose of the study
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?

The people assessing the outcomes
Intervention assignment
Other design features
Phase 2/Phase 3
Type of endpoint(s)
Statistical methods / analysis

Recruitment status
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Date of last participant enrolment
Date of last data collection
Sample size
Accrual to date
Recruitment in Australia
Recruitment state(s)
Recruitment hospital [1] 0 0
Princess Alexandra Hospital - Woolloongabba
Recruitment postcode(s) [1] 0 0
4102 - Woolloongabba

Funding & Sponsors
Primary sponsor type
Princess Alexandra Hospital, Brisbane, Australia

Ethics approval
Ethics application status

Brief summary
Between 30% and 88% of chemotherapy patients receiving docetaxel experience side effects of
the hand ranging from skin and nail disfigurement, blistering, desquamation, pain, infection,
and impaired treatment-related quality of life and function. Preliminary data indicate that
nurse-initiated cryotherapy during treatment may lower the incidence and severity of these
side effects, but several issues should be addressed before this intervention is implemented
in hospital settings. These include more rigorous study design, larger sampling frames, and
consideration of infection control concerns. This study will address these issues, thereby
rigorously evaluating the safety and efficacy of nurse-initiated cryotherapy at Princess
Alexandra Hospital.
Trial website
Trial related presentations / publications
Public notes

Principal investigator
Name 0 0
Alexandra McCarthy, PhD
Address 0 0
Queensland University of Technology
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

Summary results
Other publications